These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

948 related items for PubMed ID: 14621031

  • 21. Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study.
    Li R, Li Y, Wen S, Wen H, Nong Y, Mo Z, Xie F, Pellegrini M.
    Hum Vaccin Immunother; 2015; 11(2):435-42. PubMed ID: 25692350
    [Abstract] [Full Text] [Related]

  • 22. Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus.
    Sirikwin S, Likanonsakul S, Waradejwinyoo S, Pattamadilok S, Kumperasart S, Chaovavanich A, Manatsathit S, Malerczyk C, Wasi C.
    Vaccine; 2009 Jul 09; 27(32):4350-4. PubMed ID: 19487057
    [Abstract] [Full Text] [Related]

  • 23. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
    Muhamuda K, Madhusudana SN, Ravi V.
    Int J Infect Dis; 2007 Sep 09; 11(5):441-5. PubMed ID: 17321182
    [Abstract] [Full Text] [Related]

  • 24. Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV).
    Malerczyk C, Vakil HB, Bender W.
    Hum Vaccin Immunother; 2013 Jul 09; 9(7):1454-9. PubMed ID: 23571224
    [Abstract] [Full Text] [Related]

  • 25. Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study.
    Sampath G, Banzhoff A, Deshpande A, Malerczyk C, Arora AK, Vakil H, Preiss S.
    Hum Vaccin Immunother; 2017 Jul 03; 13(7):1531-1538. PubMed ID: 28406752
    [Abstract] [Full Text] [Related]

  • 26. Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group.
    Lang J, Simanjuntak GH, Soerjosembodo S, Koesharyono C.
    Bull World Health Organ; 1998 Jul 03; 76(5):491-5. PubMed ID: 9868840
    [Abstract] [Full Text] [Related]

  • 27. Antibodies induced by vaccination with purified chick embryo cell culture vaccine (PCECV) cross-neutralize non-classical bat lyssavirus strains.
    Malerczyk C, Selhorst T, Tordo N, Moore S, Müller T.
    Vaccine; 2009 Aug 27; 27(39):5320-5. PubMed ID: 19615958
    [Abstract] [Full Text] [Related]

  • 28. Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa.
    Sudarshan MK, Madhusudana SN, Mahendra BJ, Narayana DH, Giri MS, Muhamuda K, Ravish HS, Venkatesh GM.
    Natl Med J India; 2006 Aug 27; 19(4):192-4. PubMed ID: 17100105
    [Abstract] [Full Text] [Related]

  • 29. [Comparison of PVRV and HDCV rabies vaccines as to immunity, reliability and protective value].
    Hacibektaşoğlu A, Inal A, Eyigün C, Barut A, Türkay FA.
    Mikrobiyol Bul; 1992 Jan 27; 26(1):26-36. PubMed ID: 1574019
    [Abstract] [Full Text] [Related]

  • 30. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
    Lang J, Cetre JC, Picot N, Lanta M, Briantais P, Vital S, Le Mener V, Lutsch C, Rotivel Y.
    Biologicals; 1998 Dec 27; 26(4):299-308. PubMed ID: 10403033
    [Abstract] [Full Text] [Related]

  • 31. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.
    Tantawichien T, Benjavongkulchai M, Limsuwan K, Khawplod P, Kaewchompoo W, Chomchey P, Sitprija V.
    Clin Infect Dis; 1999 May 27; 28(5):1100-3. PubMed ID: 10452642
    [Abstract] [Full Text] [Related]

  • 32. Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine.
    Beran J, Honegr K, Banzhoff A, Malerczyk C.
    Vaccine; 2005 Jun 10; 23(30):3902-7. PubMed ID: 15917111
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Immunogenicity and efficacy of an in-house developed cell-culture derived veterinarian rabies vaccine.
    Kallel H, Diouani MF, Loukil H, Trabelsi K, Snoussi MA, Majoul S, Rourou S, Dellagi K.
    Vaccine; 2006 May 29; 24(22):4856-62. PubMed ID: 16600442
    [Abstract] [Full Text] [Related]

  • 37. Clinical evaluation of purified vero-cell rabies vaccine in patients bitten by rabid animals in India.
    Sehgal S, Bhattacharya D, Bhardwaj M.
    J Commun Dis; 1994 Sep 29; 26(3):139-46. PubMed ID: 7868836
    [Abstract] [Full Text] [Related]

  • 38. Intradermal simulated rabies postexposure prophylaxis using purified chick embryo rabies vaccine.
    Charanasri U, Meesomboon V, Kingnate D, Samuthananon P, Chaeychomsri W.
    J Med Assoc Thai; 1992 Nov 29; 75(11):639-43. PubMed ID: 1307387
    [Abstract] [Full Text] [Related]

  • 39. [Serological effect after immunization with rabies vaccine of different doses].
    Chen AZ, Kong FJ, Mei ZQ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Jun 29; 17(3):139-40. PubMed ID: 9208508
    [Abstract] [Full Text] [Related]

  • 40. What happens if intradermal injections of rabies vaccine are partially or entirely injected subcutaneously?
    Phanuphak P, Khaoplod P, Benjavongkulchai M, Chutivongse S, Wilde H.
    Bull World Health Organ; 1990 Jun 29; 68(1):83-5. PubMed ID: 2347035
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.